Search Results - "KASHENTSEVA, Elena"
-
1
Efficient Genome Editing Achieved via Plug-and-Play Adenovirus Piggyback Transport of Cas9/gRNA Complex on Viral Capsid Surface
Published in ACS nano (26-07-2022)“…The capacity to efficiently deliver the gene-editing enzyme complex to target cells is favored over other forms of gene delivery as it offers one-time…”
Get full text
Journal Article -
2
Long-term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9
Published in Journal of controlled release (28-03-2019)“…Hemophilia B (HB) is a life-threatening inherited disease caused by mutations in the FIX gene, leading to reduced protein function and abnormal blood clotting…”
Get full text
Journal Article -
3
Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9
Published in Gene therapy (01-04-2018)“…Serum deficiency diseases such as alpha-1-antitrypsin deficiency are characterized by reduced function of serum proteins, caused by deleterious genetic…”
Get full text
Journal Article -
4
An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
Published in Cell reports (Cambridge) (27-07-2021)“…SARS-CoV-2 variants that attenuate antibody neutralization could jeopardize vaccine efficacy. We recently reported the protective activity of an intranasally…”
Get full text
Journal Article -
5
Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection
Published in Nature immunology (01-03-2024)“…A nasally delivered chimpanzee adenoviral-vectored severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (ChAd-SARS-CoV-2-S) is currently used…”
Get full text
Journal Article -
6
Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer
Published in PloS one (21-12-2017)“…Clinical application of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-based cancer therapeutics has not reached optimal potencies in part due…”
Get full text
Journal Article -
7
Prolonged prophylactic protection from botulism with a single adenovirus treatment promoting serum expression of a VHH-based antitoxin protein
Published in PloS one (29-08-2014)“…Current therapies for most acute toxin exposures are limited to administration of polyclonal antitoxin serum. We have shown that VHH-based neutralizing agents…”
Get full text
Journal Article -
8
Author Correction: Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection
Published in Nature immunology (01-03-2024)Get full text
Journal Article -
9
Adenoviral vectors infect B lymphocytes in vivo
Published in Molecular therapy (06-09-2023)“…B cells are the antibody-producing arm of the adaptive immune system and play a critical role in controlling pathogens. Several groups have now demonstrated…”
Get full text
Journal Article -
10
A Gorilla Adenovirus-Based Vaccine against Zika Virus Induces Durable Immunity and Confers Protection in Pregnancy
Published in Cell reports (Cambridge) (03-09-2019)“…The teratogenic potential of Zika virus (ZIKV) has made the development of an effective vaccine a global health priority. Here, we generate two gorilla…”
Get full text
Journal Article -
11
A New Gorilla Adenoviral Vector with Natural Lung Tropism Avoids Liver Toxicity and Is Amenable to Capsid Engineering and Vector Retargeting
Published in Journal of virology (04-05-2020)“…Human adenoviruses have many attractive features for gene therapy applications. However, the high prevalence of preexisting immunity against these viruses in…”
Get full text
Journal Article -
12
Engineering a Novel Modular Adenoviral mRNA Delivery Platform Based on Tag/Catcher Bioconjugation
Published in Viruses (01-11-2023)“…mRNA vaccines have attracted widespread research attention with clear advantages in terms of molecular flexibility, rapid development, and potential for…”
Get full text
Journal Article -
13
Retraction Notice to: Insulin-like Growth Factor-binding Protein-7 (IGFBP7): A Promising Gene Therapeutic for Hepatocellular Carcinoma (HCC)
Published in Molecular therapy (01-02-2023)Get full text
Journal Article -
14
Targeting Tumor Neoangiogenesis via Targeted Adenoviral Vector to Achieve Effective Cancer Gene Therapy for Disseminated Neoplastic Disease
Published in Molecular cancer therapeutics (01-03-2020)“…The application of cancer gene therapy has heretofore been restricted to local, or locoregional, neoplastic disease contexts. This is owing to the lack of gene…”
Get full text
Journal Article -
15
A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria Vaccine
Published in PloS one (29-04-2016)“…A malaria vaccine is a public health priority. In order to produce an effective vaccine, a multistage approach targeting both the blood and the liver stage…”
Get full text
Journal Article -
16
Advanced genetic engineering to achieve in vivo targeting of adenovirus utilizing camelid single domain antibody
Published in Journal of controlled release (10-06-2021)“…For the developing field of gene therapy the successful address of the basic requirement effective gene delivery has remained a critical barrier. In this…”
Get full text
Journal Article -
17
A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer
Published in Gynecologic oncology (01-09-2013)“…Abstract Objective The conditionally replicative adenovirus Ad5/3-Δ24 has a type-3 knob incorporated into the type-5 fiber that facilitates enhanced ovarian…”
Get full text
Journal Article -
18
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates
Published in Nature immunology (01-10-2024)“…A mucosal route of vaccination could prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication at the site of infection and limit…”
Get full text
Journal Article -
19
A Tetraspecific VHH-Based Neutralizing Antibody Modifies Disease Outcome in Three Animal Models of Clostridium difficile Infection
Published in Clinical and vaccine immunology (01-09-2016)“…Clostridium difficile infection (CDI), a leading cause of nosocomial infection, is a serious disease in North America, Europe, and Asia. CDI varies greatly…”
Get full text
Journal Article -
20
Development of an adenovirus vector vaccine platform for targeting dendritic cells
Published in Cancer gene therapy (01-02-2018)“…Adenoviral (Ad) vector vaccines represent one of the most promising modern vaccine platforms, and Ad vector vaccines are currently being investigated in human…”
Get full text
Journal Article